Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             190 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 ADP-ribosylation of guanine nucleotide regulatory proteins Ui, M.
1990
183 1 p. 136-137
2 p.
artikel
2 Adverse immune reactions to a gold(I) drug are directed to gold(III), not gold(I). Detection by the popliteal lymphnode assay (PLNA) Gleichmann, E.
1990
183 1 p. 78-79
2 p.
artikel
3 Agonists, inverse agonists, and antagonists of benzodiazepine receptors Haefely, W.E.
1990
183 1 p. 38-
1 p.
artikel
4 Analysis of transmitter actions on dissociated retinal neurons Kaneko, A.
1990
183 1 p. 134-135
2 p.
artikel
5 A novel in vivo model of 5-HT1A function in the rat: 8-OH-DFAT-induced spontaneous tail-flicks Millan, M.J.
1990
183 1 p. 138-
1 p.
artikel
6 A novel protective mechanism: sensory nerve-mediated gastric mucosal vasodilatation Holzer, P.
1990
183 1 p. 128-
1 p.
artikel
7 Antimicrobial properties of quinolones Shah, P.M.
1990
183 1 p. 67-
1 p.
artikel
8 Audio-visual tools in teaching pharmacology Brune, K.
1990
183 1 p. 66-
1 p.
artikel
9 Author index 1990
183 1 p. i-lxviii
nvt p.
artikel
10 Autoantibodies to cytochrome P-450 in drug-induced hepatitis in man Beaune, P.H.
1990
183 1 p. 80-
1 p.
artikel
11 Basic mechanisms and pre clinical assessment of antiepileptic drags in the soviet union Chankvetadze, B.
1990
183 1 p. 24-
1 p.
artikel
12 Behavioural approach to the study of the central nervous system Iversen, S.D.
1990
183 1 p. 50-51
2 p.
artikel
13 Bioassay, past and present Burgen, A.S.V.
1990
183 1 p. 49-
1 p.
artikel
14 Biogenic amine receptor regulation: rules and exceptions Leysen, I.E.
1990
183 1 p. 2-
1 p.
artikel
15 Botulinum ADP-ribosyltransferase C3, a pharmacological tool to examine function and transduction pathway of the rho gene products, the small molecular weight GTP-binding proteins Narumiya, S.
1990
183 1 p. 33-
1 p.
artikel
16 Brainstem endorphinergic mechanism in the regulation of blood pressure and heart rate Kunos, G.
1990
183 1 p. 7-8
2 p.
artikel
17 Calcium antagonists (CAs) and age-related neural disorders Scriabine, A.
1990
183 1 p. 58-
1 p.
artikel
18 Calcium antagonists in the therapy of migraine Olesen, J.
1990
183 1 p. 57-58
2 p.
artikel
19 Calcium regulation in resistance vessels van Breemen, C.
1990
183 1 p. 8-9
2 p.
artikel
20 Catechol-O-methyltransferase inhibitors: their role in the therapy of Parkinson's disease (PD) Da Prada, M.
1990
183 1 p. 4-5
2 p.
artikel
21 Cellular and subcellular localization of peripheral benzodiazepine receptors: Implications for a possible function in the control of intermediary metabolism Anholt, R.R.H.
1990
183 1 p. 145-146
2 p.
artikel
22 Changes in Ca2+ channels during ischaemia Nayler, W.G.
1990
183 1 p. 26-
1 p.
artikel
23 Circulating blood cells: a suitable tool to investigate human cardiovascular pharmacology? Brodde, O.-E.
1990
183 1 p. 152-
1 p.
artikel
24 Clinical efficacy and saftey of omeprazole Olbe, L.
1990
183 1 p. 22-23
2 p.
artikel
25 Clinical evidence for the role of serotonin (5HT) in anxiety ami depression Wakelin, J.S.
1990
183 1 p. 133-
1 p.
artikel
26 Clinical pharmacology of the selective enkephalinase inhibitors SCH 32615/34826 Chipkin, R.E.
1990
183 1 p. 78-
1 p.
artikel
27 Clinical trials of potassium channel openers Carlsen, J.E.
1990
183 1 p. 70-71
2 p.
artikel
28 Conditioned drug effects Goudie, A.J.
1990
183 1 p. 98-
1 p.
artikel
29 Contraceptive vaccine development Aitken, R.J.
1990
183 1 p. 13-
1 p.
artikel
30 Control of renal blood flow by circulating and local hormones Hofbauer, K.G.
1990
183 1 p. 44-
1 p.
artikel
31 Control of the peripheral resistance: which vessels? Mulvany, M.J.
1990
183 1 p. 64-
1 p.
artikel
32 Conversion of somatostatin to an opioid peptide: design using a conformational template and topographical constraints Hruby, V.J.
1990
183 1 p. 54-55
2 p.
artikel
33 Correlation between biochemical and biological properties of thrombolytic agents Collen, D.
1990
183 1 p. 123-
1 p.
artikel
34 Corticosteroid receptor function in the brain De Kloet, E.R.
1990
183 1 p. 125-
1 p.
artikel
35 Criteria for drug registration Griffin, J.P.
1990
183 1 p. 18-19
2 p.
artikel
36 Cytokines: synthesis and release by epidermal cells under conditions of inflammation Luger, T.A.
1990
183 1 p. 130-
1 p.
artikel
37 Debate: Nootropics yes or no! Kanowski, S.
1990
183 1 p. 84-
1 p.
artikel
38 Differential effects of intracerebroventricular μ and δ selective opioids on small and large intestinal motility and transit in the rat Burks, T.F.
1990
183 1 p. 139-140
2 p.
artikel
39 Direct comparisons of streptokinase versus anistreplase Anderson, J.L.
1990
183 1 p. 123-124
2 p.
artikel
40 Discovery by serendipity Lembeck, F.
1990
183 1 p. 86-
1 p.
artikel
41 Distribution and function of enkephalinase: implications for inhibitor therapy Erdös, E.G.
1990
183 1 p. 77-
1 p.
artikel
42 3D-QSAR: known and unknown receptors Marshall, G.R.
1990
183 1 p. 15-
1 p.
artikel
43 Drag targeting by site-specific chemical drug delivery systems Bodor, N.
1990
183 1 p. 119-120
2 p.
artikel
44 Drugs as positive reinforcing and punishing stimuli Hoffmeister, F.
1990
183 1 p. 97-
1 p.
artikel
45 Drug transport related effects in the kidney. The example of diuretics Odlind, B.G.
1990
183 1 p. 102-103
2 p.
artikel
46 Early testing off experimental antiepileptic drags in humans Binnie, C.D.
1990
183 1 p. 23-
1 p.
artikel
47 Editorial Board 1990
183 1 p. IFC-
1 p.
artikel
48 Effects of calcium-antagonists on cerebral ischemia Hartmann, A.
1990
183 1 p. 57-
1 p.
artikel
49 Endogeneous brain opioid peptides and blood pressure regulation de Jong, W.
1990
183 1 p. 6-
1 p.
artikel
50 Endogenous factors that selectively modify drug metabolism Kato, R.
1990
183 1 p. 41-42
2 p.
artikel
51 Endothelium-dependent contractile modulation in cerebral artery Fujiwara, M.
1990
183 1 p. 108-109
2 p.
artikel
52 Endothelium-derived relaxing and contracting factor: pathological and therapeutic implications Vanhoutte, P.M.
1990
183 1 p. 109-110
2 p.
artikel
53 Enkephalinase inhibitors: potential therapeutic applications in gastroenterology and the cardiovascular field Schwartz, J.-C.
1990
183 1 p. 76-77
2 p.
artikel
54 Enorphins and drug seeking behaviour van Ree, J.M.
1990
183 1 p. 39-
1 p.
artikel
55 Excitatory amino acid receptors and channels Garthwaite, J.
1990
183 1 p. 150-
1 p.
artikel
56 Factors determining the kinetics of percutaneous absorption Guy, R.H.
1990
183 1 p. 129-130
2 p.
artikel
57 Fatty acid ω-hydroxylases Ortiz de Montellano, P.R.
1990
183 1 p. 95-
1 p.
artikel
58 Features of the potassium channel in vascular smooth muscle cells and their modulating drugs Kuriyama, H.
1990
183 1 p. 69-
1 p.
artikel
59 From endothelium-derived relaxing factor to nitric oxide. The role of vascular endothelium in the control of blood flow Moncada, S.
1990
183 1 p. 109-
1 p.
artikel
60 Functional aspects of peripheral benzodiazepine receptors Gavish, M.
1990
183 1 p. 144-
1 p.
artikel
61 Functional pharmacologic receptor classification: are the problems real or theoretical? Bond, R.A.
1990
183 1 p. 82-
1 p.
artikel
62 Functional plasticity after lesion of aminergic pathways Le Moal, M.
1990
183 1 p. 31-32
2 p.
artikel
63 Future strategies in the treatment of Parkinson's disease Cools, A.R.
1990
183 1 p. 5-
1 p.
artikel
64 GABAA receptor regulation after repeated administration of negative and positive modulators Biggio, G.
1990
183 1 p. 3-
1 p.
artikel
65 Genetic and environmental causes of variability in drug response Vesell, E.S.
1990
183 1 p. 111-
1 p.
artikel
66 G-proteins and the regulation of effector function Iyengar, R.
1990
183 1 p. 121-122
2 p.
artikel
67 Growth factors and manipulation of animal growth Holder, A.T.
1990
183 1 p. 12-
1 p.
artikel
68 Growth factors and their physiological implications for development Hill, D.J.
1990
183 1 p. 11-12
2 p.
artikel
69 Homeopathy placebo therapy? Ariëns, E.J.
1990
183 1 p. 153-
1 p.
artikel
70 Immunotoxins for clinical applications Baldwin, R.W.
1990
183 1 p. 46-47
2 p.
artikel
71 Influence of macromolecular synthesis and memory consolidation Matthies, H.
1990
183 1 p. 71-
1 p.
artikel
72 Inhibition by interferon (IFN) of the development of hepatic and splenic metastases in mice: role of host mechanisms Gresser, I.
1990
183 1 p. 113-
1 p.
artikel
73 Inhibition of sympathetic outflow by methionine enkephalin as a mechanism of central opioid action Rhee, H.M.
1990
183 1 p. 7-
1 p.
artikel
74 Inhibitory monoclonal antibodies and cDNA expression for the characterization of cytochrome P450 function Gelboin, H.V.
1990
183 1 p. 42-
1 p.
artikel
75 Inositol lipids and calcium signalling Berridge, M.J.
1990
183 1 p. 84-85
2 p.
artikel
76 Interactions between PAF, cytokines and FcϵRII/CD23 receptors in the control of allergic and inflammatory processes Braquet, P.
1990
183 1 p. 75-76
2 p.
artikel
77 Intravital microscopy and microcirculation: pharmacological applications De Clerck, F.
1990
183 1 p. 65-
1 p.
artikel
78 In vitro forecasting of genetic and environmental effects on drug oxidation Dayer, P.
1990
183 1 p. 59-60
2 p.
artikel
79 Is homoeopathy a placebo therapy? Kennedy, C.O.
1990
183 1 p. 154-
1 p.
artikel
80 Isolated perfused porcine skin flap model Riviere, J.E.
1990
183 1 p. 129-
1 p.
artikel
81 Is the gastric lipoxygenase system A target protective drugs? Peskar, B.M.
1990
183 1 p. 126-127
2 p.
artikel
82 Limitations and possibilities of magnetic resonance in drag imaging and spectroscopy Seelig, J.
1990
183 1 p. 81-82
2 p.
artikel
83 Linear and nonlinear system analysis approaches applied to analyze kinetic and mechanistic problems in pharmacology Veng-Pedersen, P.
1990
183 1 p. 31-
1 p.
artikel
84 Localization and function of components of the β-adrenergic system in human and blood vessels Summers, R.J.
1990
183 1 p. 151-
1 p.
artikel
85 Malaria vaccine development Martinez, L.
1990
183 1 p. 63-
1 p.
artikel
86 Mechanism of acid secretion by the parietal cell Sewing, K.-Fr.
1990
183 1 p. 21-
1 p.
artikel
87 Mechanisms of drug resistance in cancer therapy Gottesman, M.M.
1990
183 1 p. 17-18
2 p.
artikel
88 Melecular biology, the new biology and pharmacology Dollery, C.T.
1990
183 1 p. 16-
1 p.
artikel
89 Metabolism and pharmacokinetics of biological response modifiers (BRMS) Bocci, V.
1990
183 1 p. 112-113
2 p.
artikel
90 Micropharmacology of spinal synaptic terminals Curtis, D.R.
1990
183 1 p. 86-87
2 p.
artikel
91 Mode of action of omeprazole and its effect on acid secretion Wallmark, E.
1990
183 1 p. 21-22
2 p.
artikel
92 Modulatory effect of somatostatin on muscarinic mechanisms in brain Miyoshi, R.
1990
183 1 p. 56-
1 p.
artikel
93 Molecular biology of vascular hypertrophy Campbell, J.H.
1990
183 1 p. 90-
1 p.
artikel
94 Molecular mechanisms of variation in drug response Meyer, U.A.
1990
183 1 p. 111-112
2 p.
artikel
95 Molecular structure and dynamics of G protein coupled receptors and their ligands Dahl, S.G.
1990
183 1 p. 14-
1 p.
artikel
96 Muscarinic acetylcholine receptor subtypes: molecular distinction and selective effector coupling Fukuda, K.
1990
183 1 p. 105-
1 p.
artikel
97 Muscarinic receptor subtypes Mutschler, E.
1990
183 1 p. 117-119
3 p.
artikel
98 Narcotics Woods, J.H.
1990
183 1 p. 37-38
2 p.
artikel
99 Neural receptors and psychotropic drugs Snyder, S.H.
1990
183 1 p. 19-20
2 p.
artikel
100 Neurobehavirol indices of recovery from unilateral sensory deprivation and lesion of the nigro-striatal system Huston, J.P.
1990
183 1 p. 32-
1 p.
artikel
101 Neurochemical aspects of opioid addiction Herz, A.
1990
183 1 p. 140-
1 p.
artikel
102 Neuroendocrine and sympathetic responses to interleukin-1 in rats Berkenbosch, F.
1990
183 1 p. 35-
1 p.
artikel
103 Neuroleptic/dopamine receptors: search for new g-linked receptors Seeman, P.
1990
183 1 p. 106-107
2 p.
artikel
104 Neuroleptics in modern psychiatry Vinar⌣, O.
1990
183 1 p. 107-108
2 p.
artikel
105 Neuropeptide metabolism in airways by neutral endopeptidase Nadel, J.A.
1990
183 1 p. 93-
1 p.
artikel
106 Neuropeptides and airway functions Widdicombe, J.G.
1990
183 1 p. 92-
1 p.
artikel
107 Neuropeptides and asthma Barnes, P.J.
1990
183 1 p. 94-
1 p.
artikel
108 Neurotransmission in afferent neurons Lembeck, F.
1990
183 1 p. 133-134
2 p.
artikel
109 Neutrophil-mediated metabolism of autoimmunity inducing drugs Rubin, R.L.
1990
183 1 p. 79-80
2 p.
artikel
110 New contraceptive delivery systems Vemer, H.M.
1990
183 1 p. 13-14
2 p.
artikel
111 Nitric oxide, a mediator of cellular communication Moncada, S.
1990
183 1 p. 158-159
2 p.
artikel
112 Octreotide: drug development of a constrained somatostatin analogue Bauer, W.
1990
183 1 p. 55-
1 p.
artikel
113 Overview of existing and future anti-ischaemic drugs Massingham, R.
1990
183 1 p. 27-
1 p.
artikel
114 Oxidative stress: reactive oxygen species in toxicology and pharmacology Sies, H.
1990
183 1 p. 49-50
2 p.
artikel
115 PAF and allergy Vargaftig, B.B.
1990
183 1 p. 73-74
2 p.
artikel
116 PAF and PAF-antagonists in animal models of bronchial hyperreactivity Nijkamp, F.P.
1990
183 1 p. 74-75
2 p.
artikel
117 Parameters for assessment of biological responses to IFNs Huber, C.H.
1990
183 1 p. 114-
1 p.
artikel
118 Patient-oriented problem solving: a fresh tasting of old wine Riker, W.K.
1990
183 1 p. 65-66
2 p.
artikel
119 Peptide receptors of the blood-brain barrier and the consequences for transport mechanisms Ermisch, A.
1990
183 1 p. 115-
1 p.
artikel
120 Peptides and memory formation Telegdy, G.
1990
183 1 p. 72-73
2 p.
artikel
121 Peptide toxins from venoms as pharmacological agents: conotoxins as examples Olivera, B.M.
1990
183 1 p. 34-
1 p.
artikel
122 Pharmaceutical and medical criteria for the selection off essential drug Merkus, F.W.H.M.
1990
183 1 p. 99-100
2 p.
artikel
123 Pharmaco-epidemiology of anti-inflammatory drugs Urquhart, J.
1990
183 1 p. 52-53
2 p.
artikel
124 Pharmacokinetics of quinolones Bergan, T.
1990
183 1 p. 68-
1 p.
artikel
125 Pharmacological actions of potassium-channel openers Weston, A.H.
1990
183 1 p. 70-
1 p.
artikel
126 Pharmacological manipulation of vasoactive mediators in gastric damage and protection Whittle, B.J.R.
1990
183 1 p. 127-128
2 p.
artikel
127 Pharmacology and the new biology van Zwieten, P.A.
1990
183 1 p. 16-17
2 p.
artikel
128 Pharmacology of cotransmissiom Lundberg, J.M.
1990
183 1 p. 156-157
2 p.
artikel
129 Pharmacology of depression and anxiety Segawa, T.
1990
183 1 p. 132-133
2 p.
artikel
130 Pharmacology of endothelin Masaki, T.
1990
183 1 p. 120-121
2 p.
artikel
131 Pharmacology of ion channels: past, present and future Narahashi, T.
1990
183 1 p. 149-
1 p.
artikel
132 Pharmacotherapy of Alzheimer's disease: present opportunities and future possibilities Reisberg, B.
1990
183 1 p. 83-
1 p.
artikel
133 Plants as sources for agents affecting cellular Ca++ regulation Pang, P.K.T.
1990
183 1 p. 28-
1 p.
artikel
134 Potential-sensitivity of calcium channels in microvessels: functional implications Mulvany, M.J.
1990
183 1 p. 10-11
2 p.
artikel
135 Preface 1990
183 1 p. V-
1 p.
artikel
136 Present state of the control of schistosomiasis Bergquist, N.R.
1990
183 1 p. 47-
1 p.
artikel
137 Protein transport through cultured brain microvessel endothelial cells, a model of the blood-brain barrier Borchardt, R.T.
1990
183 1 p. 114-
1 p.
artikel
138 Psychological factors related to variability in drug response Netter, P.S.
1990
183 1 p. 110-
1 p.
artikel
139 Psychotropic drug effects and the peripheral benzodiazepine receptors Saano, V.
1990
183 1 p. 144-145
2 p.
artikel
140 Quantitative imaging techniques in pharmacological in vivo drug studies Hantraye, Ph.
1990
183 1 p. 81-
1 p.
artikel
141 Rationale versus serendipity in pharmacology; the case for rationale Black, J.W.
1990
183 1 p. 85-
1 p.
artikel
142 Recent advances in the chemotherapy of malaria Warhurst, D.C.
1990
183 1 p. 62-
1 p.
artikel
143 Recent studies on Chinese meteria medica for calcium antagonists Zhengang, W.
1990
183 1 p. 29-30
2 p.
artikel
144 Receptor-mediated gene delivery and expression in hepatocytes Wu, G.Y.
1990
183 1 p. 147-
1 p.
artikel
145 Receptor modulation and cAMP dependent phosphorylation system after repeated antidepressant administration Racagni, G.
1990
183 1 p. 1-
1 p.
artikel
146 Reflex cardiovascular control in health and cardiovascular disease Mancia, G.
1990
183 1 p. 117-
1 p.
artikel
147 Renal drug transport and disposition De Broe, M.E.
1990
183 1 p. 101-102
2 p.
artikel
148 Renal effects of thromboxane synthesis inhibitors and receptor antagonists Patrono, C.
1990
183 1 p. 143-
1 p.
artikel
149 Renal vasodilation: pathophysiological and therapeutic implications Hall, J.E.
1990
183 1 p. 45-
1 p.
artikel
150 Role of guanine nucleotide-binding proteins in regulation of adenylyl cyclase Jakobs, K.H.
1990
183 1 p. 137-
1 p.
artikel
151 Role of herbal medicine in geriatrics Orimo, H.
1990
183 1 p. 29-
1 p.
artikel
152 Role played by interleukin-1 (IL-1) in the regulation of nerve growth factor (NGF) synthesis under physiological and pathophysiological conditions Thoeneu, H.
1990
183 1 p. 36-37
2 p.
artikel
153 Scientific and ethical reasons for the use of alternative methods in new drug development Balls, M.
1990
183 1 p. 130-131
2 p.
artikel
154 Selective inhibition of glucuronidation and sulfation in vitro and in vivo Mulder, G.J.
1990
183 1 p. 43-
1 p.
artikel
155 Selective killing of malignant cells fey antibody-ricin conjugates (‘immunotoxins’) Thorpe, P.
1990
183 1 p. 146-147
2 p.
artikel
156 Selective renal vasodilation: pharmacological approaches Struyker Boudier, H.A.J.
1990
183 1 p. 46-
1 p.
artikel
157 Sensitivity of the mesenteric vascular bed in three rat models of hypertension Fleming, W.W.
1990
183 1 p. 91-
1 p.
artikel
158 Sites of renal prostaglandin production Herman, A.G.
1990
183 1 p. 141-142
2 p.
artikel
159 Small versus large cardiovascular trials Sleight, P.
1990
183 1 p. 155-156
2 p.
artikel
160 Small versus large cardiovascular trials Maseri, A.
1990
183 1 p. 155-
1 p.
artikel
161 Steroid and thyroid hormones and neural plasticity McEwen, B.S.
1990
183 1 p. 124-
1 p.
artikel
162 Stimulus properties of drugs Järbe, T.U.C.
1990
183 1 p. 96-97
2 p.
artikel
163 Structure and function of neurotransmitter receptors and ionic channels Numa, S.
1990
183 1 p. 157-158
2 p.
artikel
164 Structure/function and new members of the catecholamine receptor family Caron, M.G.
1990
183 1 p. 104-
1 p.
artikel
165 Study designs in drug epidemiology McNeil, J.J.
1990
183 1 p. 116-
1 p.
artikel
166 Synaptic plasticity, NMDA receptors and learning Morris, R.G.M.
1990
183 1 p. 72-
1 p.
artikel
167 Syntheis and effects of leukotrienes and other lipoxgenase products of arachidonic acid in the kidney Ardaillou, R.
1990
183 1 p. 142-
1 p.
artikel
168 Synthetic interleukin 1 fragments with agonist activity Boraschi, D.
1990
183 1 p. 35-36
2 p.
artikel
169 System dynamics and chaos theory in drug action van Rossum, J.M.
1990
183 1 p. 30-
1 p.
artikel
170 Targeting of drugs by endogenous transport vehicles van Berkel, Th.J.C.
1990
183 1 p. 148-
1 p.
artikel
171 The adrenergic receptors: structure/function and regulation Lefkowitz, R.J.
1990
183 1 p. 53-
1 p.
artikel
172 The arthritic rat as a model of clinical pain? Besson, J.M.
1990
183 1 p. 100-101
2 p.
artikel
173 The changing role of drugs in malaria control Wernsdorfer, W.H.
1990
183 1 p. 61-62
2 p.
artikel
174 The detection of adverse drug reactions in the elderly Bulpitt, C.J.
1990
183 1 p. 115-116
2 p.
artikel
175 The essential drug concept-ten years on Dunne, J.F.
1990
183 1 p. 99-
1 p.
artikel
176 The experimental deign and analysis of in vivo studies of polymorphic drug oxidation Tucker, G.T.
1990
183 1 p. 60-61
2 p.
artikel
177 The implications of increased iron in parkinsonian substantia nigra and its high affinity binding to melanin for dopamine neuron degeneration Riederer, P.
1990
183 1 p. 3-4
2 p.
artikel
178 The molecular pharmacology of GABAA/benzodiazepine receptors Seeburg, P.H.
1990
183 1 p. 104-105
2 p.
artikel
179 The need for animal models of chronic pain: the point of view of a clinician Gybels, J.
1990
183 1 p. 100-
1 p.
artikel
180 The pharmacokinetics and clinical importance of polymorphic drug oxidation Wilkinson, G.R.
1990
183 1 p. 59-
1 p.
artikel
181 The role of lipid metabolites in calcium mobilisation during ischaemia: potential new therapies Spedding, M.
1990
183 1 p. 25-
1 p.
artikel
182 The use of cultured animal and human hepatocytes in studies of drug metabolism and hepatotoxicity Guillouzo, A.
1990
183 1 p. 131-132
2 p.
artikel
183 Thromboxane and prostacyclin synthases Ullrich, V.
1990
183 1 p. 95-96
2 p.
artikel
184 Treatment of mild heart failure: atrial natriuretic peptide and angiotensin converting enzyme inhibition Riegger, A.J.G.
1990
183 1 p. 41-
1 p.
artikel
185 Treatment of schistosomiasis-scene setting Vanden Bossche, H.
1990
183 1 p. 48-
1 p.
artikel
186 Trends in the treatment of mild heart failure: new positive inotropic agents Ravens, U.
1990
183 1 p. 40-
1 p.
artikel
187 Typical and atypical neuroleptics; similarity and dissimilarity features Rayevsky, K.S.
1990
183 1 p. 105-106
2 p.
artikel
188 Vascular hypertrophy caused by sympathetic denervation Osswald, W.
1990
183 1 p. 89-
1 p.
artikel
189 Vascular smooth muscle calcium channels Benham, C.D.
1990
183 1 p. 9-10
2 p.
artikel
190 Vasopressin and oxytocin receptors: agonists and antagonists Jard, S.
1990
183 1 p. 87-88
2 p.
artikel
                             190 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland